Hyaluronan-enriched transfer media in PGT-A cycles: a stratified cohort analysis
Reproductive BioMedicine Online · 2026
DOI: 10.1016/j.rbmo.2025.105235 ↗Kurz gefasst
Fachartikel in der Zeitschrift Reproductive BioMedicine Online, 2026. Verfasst von Pierfrancesco Greco und 8 weiteren Autor:innen. Beteiligte Einrichtung: Villa Mafalda, Centre for Reproductive Medicine, Rome, Italy. Hauptthemen laut MEDLINE: Hyaluronic Acid, Embryo Transfer, Preimplantation Diagnosis, Culture Media. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.
Abstract (Originalsprache)
RESEARCH QUESTION: Can hyaluronan-enriched transfer medium (HETM) improve reproductive outcomes in frozen single euploid blastocyst transfers after preimplantation genetic testing for aneuploidy (PGT-A)? DESIGN: Retrospective analysis of 445 patients (549 cycles), who had PGT-A embryo transfers that used HETM (EmbryoGlue) versus standard medium. Subgroup analyses were conducted based on blastocyst morphology, maternal age and previous implantation failure. RESULTS: No significant differences were found between HETM and control groups in the main reproductive outcomes, including positive HCG rates (72.27% versus 70.23%, P = 0.648), clinical pregancy rates per positive BHCG (80.23% versus 84.11%, P = 0.440), live birth rates (66.28% versus 72.85%, P = 0.237), and miscarriage rates (13.95% and 11.26%, P = 0.404). Subgroup analyses by blastocyst cohort quality, maternal age and previous implantation failure showed no statistically significant benefit of HETM. On transfers of poor morphology (C-grade) blastocysts, HETM was associated with a significantly higher HCG-positive rate (79.17% for HETM versus 52.94% for the control group, P = 0.021), but this did not translate into improved clinical pregnancy (52.63% HETM versus 68.89% control group; P = 0.231) or live birth rates (47.37% HETM versus 62.22% control group; P = 0.284). CONCLUSIONS: HETM did not provide a significant advantage in reproductive outcomes after single euploid blastocyst transfer. Its limited benefit in specific subgroups, such as poor morphology embryos, warrants cautious use and further research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Villa Mafalda, Centre for Reproductive Medicine, Rome, Italy.
- Villa Mafalda, Centre for Reproductive Medicine, Rome, Italy.; Sant'Andrea Hospital, Department of Surgical and Medical Sciences and Translational Medicine, Sapienza University of Rome, Italy.. Electronic address: costa…
- Villa Mafalda, Centre for Reproductive Medicine, Rome, Italy.; Department of Obstetrics and Gynecology, UniCamillus, International Medical University, Rome, Italy.
Zitieren
APA
Greco, P., Costanzi, F., Listorti, I., Varricchio, M. T., Litwicka, K., Arrivi, C., Mencacci, C., Greco, E., & Colasante, A. (2026). Hyaluronan-enriched transfer media in PGT-A cycles: a stratified cohort analysis. Reproductive BioMedicine Online. https://doi.org/10.1016/j.rbmo.2025.105235
Vancouver
Greco P, Costanzi F, Listorti I, Varricchio MT, Litwicka K, Arrivi C, et al. Hyaluronan-enriched transfer media in PGT-A cycles: a stratified cohort analysis. Reproductive BioMedicine Online. 2026. doi:10.1016/j.rbmo.2025.105235
BibTeX
@article{Greco2026,
author = {Greco, Pierfrancesco and Costanzi, Flavia and Listorti, Ilaria and Varricchio, Maria Teresa and Litwicka, Katarzyna and Arrivi, Cristiana and Mencacci, Cecilia and Greco, Ermanno and Colasante, Alessandro},
title = {Hyaluronan-enriched transfer media in PGT-A cycles: a stratified cohort analysis},
journal = {Reproductive BioMedicine Online},
year = {2026},
doi = {10.1016/j.rbmo.2025.105235}
}
EUVIMED